Toshihiro Nanki

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Rheumatoid Arthritis

Interstitial Lung Disease

Monoclonal Antibody

Top Venues

Journal of clinical medicine

Modern rheumatology case reports

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mai Kawazoe, Toshihiro Nanki
Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis. Lupus (2024)
Mai Kawazoe, Toshihiro Nanki, Keigo Saeki, Hideki Ishikawa, Yoshikazu Nakamura, Soko Kawashima, Shuichi Ito, Masanari Kodera, Naoko Konda, Shinya Kaname, Masayoshi Harigai
Nationwide epidemiological survey of polyarteritis nodosa in Japan in 2020. Modern rheumatology (2024)
Shotaro Masuoka, Takashi Tanaka, Miwa Kanaji, Karin Furukawa, Keiko Koshiba, Zento Yamada, Eri Watanabe, Mai Kawazoe, Shun Ito, Ayako Fuchigami, Toshihiro Nanki
A case of systemic lupus erythematosus in a patient with Noonan syndrome with recurrent severe hypoglycaemia. Modern rheumatology case reports 8 (2) (2024)
Mai Kawazoe, Toshihiro Nanki
Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis. Lupus 33 (4) (2024)
Shotaro Masuoka, Takashi Tanaka, Miwa Kanaji, Karin Furukawa, Keiko Koshiba, Zento Yamada, Eri Watanabe, Mai Kawazoe, Shun Ito, Ayako Fuchigami, Toshihiro Nanki
A case of systemic lupus erythematosus in a patient with Noonan syndrome with recurrent severe hypoglycemia. Modern rheumatology case reports (2024)
Mai Kawazoe, Toshihiro Nanki
Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis. Lupus 33 (4) (2024)
Shotaro Masuoka, Takashi Tanaka, Miwa Kanaji, Karin Furukawa, Keiko Koshiba, Zento Yamada, Eri Watanabe, Mai Kawazoe, Shun Ito, Ayako Fuchigami, Toshihiro Nanki
A case of systemic lupus erythematosus in a patient with Noonan syndrome with recurrent severe hypoglycaemia. Modern rheumatology case reports 8 (2) (2024)
Toshihiro Nanki, Mai Kawazoe, Kiyoko Uno, Wataru Hirose, Hiroaki Dobashi, Hiroshi Kataoka, Toshihide Mimura, Hiroshi Hagino, Hajime Kono
Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial. Journal of clinical medicine 12 (1) (2022)
Wataru Hirose, Masayoshi Harigai, Koichi Amano, Toshihiko Hidaka, Kenji Itoh, Kazutoshi Aoki, Masahiro Nakashima, Hayato Nagasawa, Yukiko Komano, Toshihiro Nanki
Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis. Rheumatology advances in practice 6 (3) (2022)
Toshihiro Nanki, Mai Kawazoe, Kiyoko Uno, Wataru Hirose, Hiroaki Dobashi, Hiroshi Kataoka, Toshihide Mimura, Hiroshi Hagino, Hajime Kono
Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial. Journal of clinical medicine 12 (1) (2022)
Toshihiro Nanki, Mai Kawazoe, Kiyoko Uno, Wataru Hirose, Hiroaki Dobashi, Hiroshi Kataoka, Toshihide Mimura, Hiroshi Hagino, Hajime Kono
Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial. Journal of clinical medicine 12 (1) (2022)
Satoshi Mizutani, Junko Nishio, Kanoh Kondo, Kaori Motomura, Zento Yamada, Shotaro Masuoka, Soichi Yamada, Sei Muraoka, Naoto Ishii, Yoshikazu Kuboi, Sho Sendo, Tetuo Mikami, Toshio Imai, Toshihiro Nanki
Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)
Mai Kawazoe, Mari Kihara, Toshihiro Nanki
Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Tomoaki Ishigami, Toshihiro Nanki, Takuya Sugawara, Kotaro Uchida, Hiroyuki Takeda, Tatsuya Sawasaki, Lin Chen, Hiroshi Doi, Kentaro Arakawa, Sae Saigo, Ryusuke Yoshimi, Masataka Taguri, Kazuo Kimura, Kiyoshi Hibi, Hiromichi Wakui, Kengo Azushima, Kouichi Tamura, null On Behalf Of Oracle Arthritis Investigators
Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis. Methods and protocols 4 (4) (2021)
Mai Kawazoe, Kaichi Kaneko, Toshihiro Nanki
Glucocorticoid therapy suppresses Wnt signaling by reducing the ratio of serum Wnt3a to Wnt inhibitors, sFRP-1 and Wif-1. Clinical rheumatology 40 (7) (2021)
Yoshiya Tanaka, Tsutomu Takeuchi, Hisashi Yamanaka, Toshihiro Nanki, Hisanori Umehara, Nobuyuki Yasuda, Fumitoshi Tago, Yasumi Kitahara, Makoto Kawakubo, Kentaro Torii, Seiichiro Hojo, Tetsu Kawano, Toshio Imai
Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study. Arthritis & rheumatology (Hoboken, N.J.) 73 (4) (2021)
Sei Muraoka, Zento Yamada, Mai Kawazoe, Wataru Hirose, Hajime Kono, Shinsuke Yasuda, Yukiko Komano, Hiroshi Kawano, Toshihiko Hidaka, Shusaku Nakashima, Tsuyoshi Kasama, Tamio Teramoto, Toshihiro Nanki, null null
Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study. Rheumatology and therapy 8 (4) (2021)
Satoshi Mizutani, Hitoshi Kodera, Yoshiko Sato, Toshihiro Nanki, Shunji Yoshida, Hidekata Yasuoka
Clinical effectiveness of iguratimod based on real-world data of patients with rheumatoid arthritis. Clinical rheumatology 40 (1) (2020)
Chie Miyabe, Yoshishige Miyabe, Jun Nagai, Noriko N Miura, Naohito Ohno, Jerold Chun, Ryoji Tsuboi, Hiroshi Ueda, Masayuki Miyasaka, Nobuyuki Miyasaka, Toshihiro Nanki
Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis. Arthritis research & therapy 21 (1) (2019)
Shotaro Masuoka, Natsuko Kusunoki, Ryo Takamatsu, Hiroshi Takahashi, Kazuaki Tsuchiya, Shinichi Kawai, Toshihiro Nanki
Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial　tissues of rheumatoid arthritis. PloS one 13 (12) (2018)